Strategies for clinical development of monoclonal antibodies beyond first-in-man trials: Tested doses and rationale for dose selection.
Journal article

Strategies for clinical development of monoclonal antibodies beyond first-in-man trials: Tested doses and rationale for dose selection.

  • Vinches, Marie Institut régional du Cancer de Montpellier - Val d’Aurelle, Montpellier, France
  • Cuenant, Alice Institut régional du Cancer de Montpellier - Val d’Aurelle, Montpellier, France
  • Alexandre, Marie Institut régional du Cancer de Montpellier - Val d’Aurelle, Montpellier, France
  • Durigova, Anna Geneva University Hospitals, Geneva, Switzerland
  • Hayaoui, Nadia Institut régional du Cancer de Montpellier - Val d’Aurelle, Montpellier, France
  • Mollevi, Caroline Institut régional du Cancer de Montpellier - Val d’Aurelle, Montpellier, France
  • Gianni, Luca San Raffaele Hospital, Milano, Italy
  • Tosi, Diego Institut régional du Cancer de Montpellier - Val d’Aurelle, Montpellier, France
Show more…
Published in:
  • Journal of Clinical Oncology. - American Society of Clinical Oncology (ASCO). - 2015, vol. 33, no. 15_suppl, p. 3040-3040
Language
  • English
Open access status
closed
Identifiers
Persistent URL
https://sonar.ch/global/documents/252475
Statistics

Document views: 28 File downloads: